Endosseous Dental Implant FailureNCT02681250
A Clinical Trial of Dental Implants in Titanium-zirconium Alloy
A study testing Titanium-zirconium and Titanium in people with Endosseous Dental Implant Failure, run by Vastra Gotaland Region at 1 site in Sweden.
Trial summary
A Randomized controlled Clinical trial which aim is to investigate the clinical outcome of dental implants in titanium-zirconium alloy compared to traditional titan-4 implants. The hypothesis is set to no difference in the clinical outcome for the two types of implants. Preliminary estimation of 96 patients needed. Read more about this study
- Who is it for?
- Ages 18 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Endosseous Dental Implant Failure
- What is being tested?
- Titanium-zirconium and Titanium
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 96 participants
- Where
- 1 siteSweden
- Study dates
- 1 Feb 2015to Jul 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- All patients in need for implant treatment
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Randomized Controlled Clinical Trial of Dental Implants in Titanium-zirconium Alloy
A Randomized controlled Clinical trial which aim is to investigate the clinical outcome of dental implants in titanium-zirconium alloy compared to traditional titan-4 implants. The hypothesis is set to no difference in the clinical outcome for the two types of implants. Preliminary estimation of 96 patients needed. A pilot study will provide us with further data in order to more accurately specify the sample number."
Read the detailed description
Background
Implants have been used for the purpose of replacing lost teeth since the 1960s. Since then, the treatment of edentulism with dental implants has been implemented in a large scale. The main reason for this is that research has shown that treatment with implants are very predictable in terms of implant survival. The accumulated knowledge, as seen from 15 and 20 year follow-ups, has been based on prerequisites that are not always followed today. One of them is that the implants used in the aforementioned studies are manufactured in titanium that has good rigidity and is used as the main implant material today. In addition, the studies have examined implants with a turned surface. This standard revised in the mid 1990s when a series of studies showed increased and accelerated osseous ingrowth of implants with a moderate raw surface that had been achieved by blasting. The related biological events describing this process have been described in detail in the literature.
Today, other materials are being explored as an alternative to the well documented implant material titanium with a focus on finding a material with higher stiffness combined with equivalent biological characteristics. A stiffer material theoretically gives possibilities for implants installations without bone augmentation in cases with reduced bone volumes.
An alternative implant material which has reached the clinic is titanium-zirconium alloy. It has been shown to have an increased rigidity in comparison with titanium and comparable biological characteristics but the documentation consists mainly of animal studies and short term clinical follow-up in the form of case-series. Since it has been demonstrated that the choice of implant material may influence osseointegration, it is necessary to evaluate the implants made of titanium-zirconium in a clinical controlled study with long-term follow-up in which the emphasis is put on the clinical outcome.
Aims
The aim of the study is to compare the clinical outcome of implants made of titanium-zirconium with a proven implants made of titanium.
The scientific question in this project is if there are differences in the clinical outcomes of an implant made of titanium and a corresponding implants in titanium-zirconium alloy.
Materials and Methods
Patients referred for implant treatment at the Department of Prosthodontics, Specialisttandvården Borås will be asked to participate in the study and provide written consent after review of delivered information sheet. Implants will be installed by two well experienced surgeons at Oral Maxillofacial Surgery att Borås Regional Hospital according to the protocol used for dental implant surgery and recommended by the manufacturer.
Two groups, matched for age and gender, will be defined after block randomisation for smoking. The test group will receive titanium-zirconium implants and the control group titanium implants. For a power of 80% and for p < 0.05, (SD = 1.66 according to previous studies, estimates made from 1 mm difference in margin bone level between the groups), the size of the groups has been defined as 44 patients per group. The investigators anticipate a loss of approximately 10% and therefore, the investigators have increased each patient group to 48 individuals. The data collection is completed when the number of patients has been reached.
The evaluation will involve no additional clinical or radiological examinations as compared to the usual procedures. Normally, this means examination and therapy planning, surgical examination, implant installation, impression, placement of prosthetic restoration, baseline X-ray, control/follow-up tightening of prosthetic screw/hygiene monitoring. No additional time or costs arises in connection with participation in the study, the cost of both groups are equivalent.
National guidelines will be followed regarding possible need of antibiotic prophylaxis. Registration will be done with regard to history of periodontal disease, smoking, medication, and implant position in the jaw.
The data collection will take place at four different times: in connection with the placement of the prosthetic construction (baseline) and after 1.3 and 5 years. Standard x-ray examinations will be carried out to check the marginal bone level which will take place through individualized x-ray holders that will be produced by impression material (Putty). Registration of pocket depth, bleeding on probing, amount of keratinized mucosa and measurements on x-ray will be done by the same person. Prosthetic complications and possible total implant loss will be registered.
The marginal bone level for each implant will be presented as the average of the mesial and distal bone level (primary outcome). The mean value of pocket depth will be recorded for each implant at a 4-point measurement. The hypothesis is to be tested with the independent samples t-test.
The impact of restoration distance from the bone level, the effect of implant type, margin bone level, bleeding on probing and pocket depth will be controlled using regression analysis. SPSS is used for statistical analysis.
The hypothesis is that there are no differences in the clinical outcomes between the two types of implants.
Potential benefits of the Project
The investigators can conclude that the materials are equivalent if there is no difference between implant types available. Since, titanium-zirconium alloy has a higher stiffness than titan, the investigators will be able to provide patients with thinner implant and thus costly and painful treatments to optimize the width of the bone in the installation area should be avoided.
From a social perspective, if it turns out that titan-zirconium have equal or better clinical performance than titanium, can unnecessary healthcare costs for surgery for modulation of the surgical site in the form of augmentation or sinus elevation associated with implant treatment should be avoided. If optimizing surgery can be avoided, this means even shorter therapy times and increased availability by the released health time which can be used to more quickly treat other patients as possible had standing in line for their treatment. Limits can be found in the study's applicability in general dentistry because all operations are carried out at specialist clinic in which case the patient clientele and the processor's level of expertise is not fully comparable with the general dentist.
Research ethical considerations
Treatment with dental implants in titanium is a known treatment that has helped to restore good chewing function for many patients and years all over the world and can be thought of as a safe treatment with high success rates. The study protocol calls for no difference in the x-ray examination or the surgical protocol as compared to the procedures followed in regular treatment basis. In previous studies, there is no listing of suspected allergy to titanium-zirconium alloy.
Patient information and storage of personal data in accordance with the recommendations of the Board of ethical review.
- Conditions
- Endosseous Dental Implant Failure
- Being tested
- Titanium-zirconium, Titanium
- Keywords
- Zirconium, Randomized Controlled Trial, Dental Implants, Dental Material, Titanium
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Titanium-zirconiumProcedure or surgery
Also called Straumann Roxolid SLA
Titanium-zirconium implants will be installed according to the protocol earlier described in the detailed description.
TitaniumProcedure or surgery
Also called Straumann SLA (Sand blasted, Large grit, Acid Etched)
Titanium implants will be installed according to the protocol earlier described in the detailed description.
| Study group | Role | What they receive |
|---|---|---|
| Titanium-zirconium | Experimental | Patients receiving titanium-zirconium implants Receives: Procedure: Titanium-zirconium |
| Titanium | Active comparator | Patients receiving titanium implants Receives: Procedure: Titanium |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in bone loss measured on X-ray (mm)
Measured: Baseline and 1 year
Secondary outcomes (4)
Change in bleeding on probing (Yes/No)
Measured: Baseline and 1 year
Change in amount of Clinical Mucosa (mm)
Measured: Baseline and 1 year
Change in Pocket depth (mm)
Measured: Baseline and 1 year
Change in Prosthetic Complications (Yes/No)
Measured: Baseline and 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2016 (estimated)
- Study start1 Feb 2015
- Primary completionDec 2020 (estimated)
- Study completionJul 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (18)Papers the sponsor has linked to this study.
- Other trials for Endosseous Dental Implant FailureStudies of the same condition, open and under way.
- More trials run by Vastra Gotaland RegionThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 96 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Vastra Gotaland Region
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Kostas Bougas, PhD, Principal investigator, Borås Regional Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02681250
- Sponsor's protocol ID
- TiZir
- Status last verified
- Nov 2019
- First submitted
- 1 Feb 2016
- Last updated
- 13 Nov 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Branemark PI, Adell R, Breine U, Hansson BO, Lindstrom J, Ohlsson A. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg. 1969;3(2):81-100. doi: 10.3109/02844316909036699. No abstract available.
PubMed 4924041Ekelund JA, Lindquist LW, Carlsson GE, Jemt T. Implant treatment in the edentulous mandible: a prospective study on Branemark system implants over more than 20 years. Int J Prosthodont. 2003 Nov-Dec;16(6):602-8.
PubMed 14714838Jemt T. Single implants in the anterior maxilla after 15 years of follow-up: comparison with central implants in the edentulous maxilla. Int J Prosthodont. 2008 Sep-Oct;21(5):400-8.
PubMed 18950060Jemt T, Ahlberg G, Henriksson K, Bondevik O. Changes of anterior clinical crown height in patients provided with single-implant restorations after more than 15 years of follow-up. Int J Prosthodont. 2006 Sep-Oct;19(5):455-61.
PubMed 17323723Wennerberg A, Albrektsson T, Andersson B. Bone tissue response to commercially pure titanium implants blasted with fine and coarse particles of aluminum oxide. Int J Oral Maxillofac Implants. 1996 Jan-Feb;11(1):38-45.
PubMed 8820121Wennerberg A, Albrektsson T, Johansson C, Andersson B. Experimental study of turned and grit-blasted screw-shaped implants with special emphasis on effects of blasting material and surface topography. Biomaterials. 1996 Jan;17(1):15-22. doi: 10.1016/0142-9612(96)80750-2.
PubMed 8962942Wennerberg A, Albrektsson T, Lausmaa J. Torque and histomorphometric evaluation of c.p. titanium screws blasted with 25- and 75-microns-sized particles of Al2O3. J Biomed Mater Res. 1996 Feb;30(2):251-60. doi: 10.1002/(SICI)1097-4636(199602)30:23.0.CO;2-P.
PubMed 9019491Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res. 2003 Jun;14(3):251-62. doi: 10.1034/j.1600-0501.2003.00972.x.
PubMed 12755774Bougas K, Jimbo R, Vandeweghe S, Hayashi M, Bryington M, Kozai Y, Schwartz-Filho HO, Tovar N, Adolfsson E, Ono D, Coelho PG, Wennerberg A. Bone apposition to laminin-1 coated implants: histologic and 3D evaluation. Int J Oral Maxillofac Surg. 2013 May;42(5):677-82. doi: 10.1016/j.ijom.2012.11.008. Epub 2012 Dec 8.
PubMed 23228694Kobayashi E, Matsumoto S, Doi H, Yoneyama T, Hamanaka H. Mechanical properties of the binary titanium-zirconium alloys and their potential for biomedical materials. J Biomed Mater Res. 1995 Aug;29(8):943-50. doi: 10.1002/jbm.820290805.
PubMed 7593037Gottlow J, Dard M, Kjellson F, Obrecht M, Sennerby L. Evaluation of a new titanium-zirconium dental implant: a biomechanical and histological comparative study in the mini pig. Clin Implant Dent Relat Res. 2012 Aug;14(4):538-45. doi: 10.1111/j.1708-8208.2010.00289.x. Epub 2010 Jun 25.
PubMed 20586785Wen B, Zhu F, Li Z, Zhang P, Lin X, Dard M. The osseointegration behavior of titanium-zirconium implants in ovariectomized rabbits. Clin Oral Implants Res. 2014 Jul;25(7):819-25. doi: 10.1111/clr.12141. Epub 2013 Feb 21.
PubMed 23432001Barter S, Stone P, Bragger U. A pilot study to evaluate the success and survival rate of titanium-zirconium implants in partially edentulous patients: results after 24 months of follow-up. Clin Oral Implants Res. 2012 Jul;23(7):873-81. doi: 10.1111/j.1600-0501.2011.02231.x. Epub 2011 Jun 24.
PubMed 21707752Benic GI, Gallucci GO, Mokti M, Hammerle CH, Weber HP, Jung RE. Titanium-zirconium narrow-diameter versus titanium regular-diameter implants for anterior and premolar single crowns: 1-year results of a randomized controlled clinical study. J Clin Periodontol. 2013 Nov;40(11):1052-61. doi: 10.1111/jcpe.12156. Epub 2013 Sep 8.
PubMed 24015975Nicolau P, Korostoff J, Ganeles J, Jackowski J, Krafft T, Neves M, Divi J, Rasse M, Guerra F, Fischer K. Immediate and early loading of chemically modified implants in posterior jaws: 3-year results from a prospective randomized multicenter study. Clin Implant Dent Relat Res. 2013 Aug;15(4):600-12. doi: 10.1111/j.1708-8208.2011.00418.x. Epub 2011 Dec 15.
PubMed 22171722
Study at a glance
From the registry record, last updated by the sponsor on 13 Nov 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Clinical Trial of Dental Implants in Titanium-zirconium Alloy
- ClinicalTrials.gov ID
- NCT02681250
- Acronym / sponsor ID
- TiZir
- Conditions
- Endosseous Dental Implant Failure
- Keywords
- Zirconium, Randomized Controlled Trial, Dental Implants, Dental Material, Titanium
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 96 participants (estimated)
- Lead sponsor
- Vastra Gotaland RegionOther government
- Study start
- 1 Feb 2015
- Primary completion
- Dec 2020 (estimated)
- Study completion
- Jul 2021 (estimated)
- First posted
- 12 Feb 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A Randomized controlled Clinical trial which aim is to investigate the clinical outcome of dental implants in titanium-zirconium alloy compared to traditional titan-4 implants. The hypothesis is set to no difference in the clinical outcome for the two types of implants. Preliminary estimation of 96 patients needed. A pilot study will provide us with further data in order to more accurately specify the sample number."
Detailed description
Background
Implants have been used for the purpose of replacing lost teeth since the 1960s. Since then, the treatment of edentulism with dental implants has been implemented in a large scale. The main reason for this is that research has shown that treatment with implants are very predictable in terms of implant survival. The accumulated knowledge, as seen from 15 and 20 year follow-ups, has been based on prerequisites that are not always followed today. One of them is that the implants used in the aforementioned studies are manufactured in titanium that has good rigidity and is used as the main implant material today. In addition, the studies have examined implants with a turned surface. This standard revised in the mid 1990s when a series of studies showed increased and accelerated osseous ingrowth of implants with a moderate raw surface that had been achieved by blasting. The related biological events describing this process have been described in detail in the literature.
Today, other materials are being explored as an alternative to the well documented implant material titanium with a focus on finding a material with higher stiffness combined with equivalent biological characteristics. A stiffer material theoretically gives possibilities for implants installations without bone augmentation in cases with reduced bone volumes.
An alternative implant material which has reached the clinic is titanium-zirconium alloy. It has been shown to have an increased rigidity in comparison with titanium and comparable biological characteristics but the documentation consists mainly of animal studies and short term clinical follow-up in the form of case-series. Since it has been demonstrated that the choice of implant material may influence osseointegration, it is necessary to evaluate the implants made of titanium-zirconium in a clinical controlled study with long-term follow-up in which the emphasis is put on the clinical outcome.
Aims
The aim of the study is to compare the clinical outcome of implants made of titanium-zirconium with a proven implants made of titanium.
The scientific question in this project is if there are differences in the clinical outcomes of an implant made of titanium and a corresponding implants in titanium-zirconium alloy.
Materials and Methods
Patients referred for implant treatment at the Department of Prosthodontics, Specialisttandvården Borås will be asked to participate in the study and provide written consent after review of delivered information sheet. Implants will be installed by two well experienced surgeons at Oral Maxillofacial Surgery att Borås Regional Hospital according to the protocol used for dental implant surgery and recommended by the manufacturer.
Two groups, matched for age and gender, will be defined after block randomisation for smoking. The test group will receive titanium-zirconium implants and the control group titanium implants. For a power of 80% and for p < 0.05, (SD = 1.66 according to previous studies, estimates made from 1 mm difference in margin bone level between the groups), the size of the groups has been defined as 44 patients per group. The investigators anticipate a loss of approximately 10% and therefore, the investigators have increased each patient group to 48 individuals. The data collection is completed when the number of patients has been reached.
The evaluation will involve no additional clinical or radiological examinations as compared to the usual procedures. Normally, this means examination and therapy planning, surgical examination, implant installation, impression, placement of prosthetic restoration, baseline X-ray, control/follow-up tightening of prosthetic screw/hygiene monitoring. No additional time or costs arises in connection with participation in the study, the cost of both groups are equivalent.
National guidelines will be followed regarding possible need of antibiotic prophylaxis. Registration will be done with regard to history of periodontal disease, smoking, medication, and implant position in the jaw.
The data collection will take place at four different times: in connection with the placement of the prosthetic construction (baseline) and after 1.3 and 5 years. Standard x-ray examinations will be carried out to check the marginal bone level which will take place through individualized x-ray holders that will be produced by impression material (Putty). Registration of pocket depth, bleeding on probing, amount of keratinized mucosa and measurements on x-ray will be done by the same person. Prosthetic complications and possible total implant loss will be registered.
The marginal bone level for each implant will be presented as the average of the mesial and distal bone level (primary outcome). The mean value of pocket depth will be recorded for each implant at a 4-point measurement. The hypothesis is to be tested with the independent samples t-test.
The impact of restoration distance from the bone level, the effect of implant type, margin bone level, bleeding on probing and pocket depth will be controlled using regression analysis. SPSS is used for statistical analysis.
The hypothesis is that there are no differences in the clinical outcomes between the two types of implants.
Potential benefits of the Project
The investigators can conclude that the materials are equivalent if there is no difference between implant types available. Since, titanium-zirconium alloy has a higher stiffness than titan, the investigators will be able to provide patients with thinner implant and thus costly and painful treatments to optimize the width of the bone in the installation area should be avoided.
From a social perspective, if it turns out that titan-zirconium have equal or better clinical performance than titanium, can unnecessary healthcare costs for surgery for modulation of the surgical site in the form of augmentation or sinus elevation associated with implant treatment should be avoided. If optimizing surgery can be avoided, this means even shorter therapy times and increased availability by the released health time which can be used to more quickly treat other patients as possible had standing in line for their treatment. Limits can be found in the study's applicability in general dentistry because all operations are carried out at specialist clinic in which case the patient clientele and the processor's level of expertise is not fully comparable with the general dentist.
Research ethical considerations
Treatment with dental implants in titanium is a known treatment that has helped to restore good chewing function for many patients and years all over the world and can be thought of as a safe treatment with high success rates. The study protocol calls for no difference in the x-ray examination or the surgical protocol as compared to the procedures followed in regular treatment basis. In previous studies, there is no listing of suspected allergy to titanium-zirconium alloy.
Patient information and storage of personal data in accordance with the recommendations of the Board of ethical review.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Titanium-zirconium | Experimental | Procedure: Titanium-zirconiumPatients receiving titanium-zirconium implants |
| Titanium | Active comparator | Procedure: TitaniumPatients receiving titanium implants |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All patients in need for implant treatment
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Titanium-zirconiumAlso: Straumann Roxolid SLATitanium-zirconium implants will be installed according to the protocol earlier described in the detailed description. | Procedure or surgery | Titanium-zirconium |
| TitaniumAlso: Straumann SLA (Sand blasted, Large grit, Acid Etched)Titanium implants will be installed according to the protocol earlier described in the detailed description. | Procedure or surgery | Titanium |
Primary outcome
Change in bone loss measured on X-ray (mm)
Time frame: Baseline and 1 year
4 secondary outcomes
Change in bleeding on probing (Yes/No)
Time frame: Baseline and 1 year
Change in amount of Clinical Mucosa (mm)
Time frame: Baseline and 1 year
Change in Pocket depth (mm)
Time frame: Baseline and 1 year
Change in Prosthetic Complications (Yes/No)
Time frame: Baseline and 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Nov 2019.
- Background: PubMed 4924041Branemark PI, Adell R, Breine U, Hansson BO, Lindstrom J, Ohlsson A. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg. 1969;3(2):81-100. doi: 10.3109/02844316909036699. No abstract available.
- Background: PubMed 14714838Ekelund JA, Lindquist LW, Carlsson GE, Jemt T. Implant treatment in the edentulous mandible: a prospective study on Branemark system implants over more than 20 years. Int J Prosthodont. 2003 Nov-Dec;16(6):602-8.
- Background: PubMed 18950060Jemt T. Single implants in the anterior maxilla after 15 years of follow-up: comparison with central implants in the edentulous maxilla. Int J Prosthodont. 2008 Sep-Oct;21(5):400-8.
- Background: PubMed 17323723Jemt T, Ahlberg G, Henriksson K, Bondevik O. Changes of anterior clinical crown height in patients provided with single-implant restorations after more than 15 years of follow-up. Int J Prosthodont. 2006 Sep-Oct;19(5):455-61.
- Background: PubMed 8820121Wennerberg A, Albrektsson T, Andersson B. Bone tissue response to commercially pure titanium implants blasted with fine and coarse particles of aluminum oxide. Int J Oral Maxillofac Implants. 1996 Jan-Feb;11(1):38-45.
- Background: PubMed 8962942Wennerberg A, Albrektsson T, Johansson C, Andersson B. Experimental study of turned and grit-blasted screw-shaped implants with special emphasis on effects of blasting material and surface topography. Biomaterials. 1996 Jan;17(1):15-22. doi: 10.1016/0142-9612(96)80750-2.
- Background: PubMed 9019491Wennerberg A, Albrektsson T, Lausmaa J. Torque and histomorphometric evaluation of c.p. titanium screws blasted with 25- and 75-microns-sized particles of Al2O3. J Biomed Mater Res. 1996 Feb;30(2):251-60. doi: 10.1002/(SICI)1097-4636(199602)30:23.0.CO;2-P.
- Background: PubMed 12755774Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res. 2003 Jun;14(3):251-62. doi: 10.1034/j.1600-0501.2003.00972.x.
- Background: PubMed 23228694Bougas K, Jimbo R, Vandeweghe S, Hayashi M, Bryington M, Kozai Y, Schwartz-Filho HO, Tovar N, Adolfsson E, Ono D, Coelho PG, Wennerberg A. Bone apposition to laminin-1 coated implants: histologic and 3D evaluation. Int J Oral Maxillofac Surg. 2013 May;42(5):677-82. doi: 10.1016/j.ijom.2012.11.008. Epub 2012 Dec 8.
- Background: PubMed 7593037Kobayashi E, Matsumoto S, Doi H, Yoneyama T, Hamanaka H. Mechanical properties of the binary titanium-zirconium alloys and their potential for biomedical materials. J Biomed Mater Res. 1995 Aug;29(8):943-50. doi: 10.1002/jbm.820290805.
- Background: PubMed 20586785Gottlow J, Dard M, Kjellson F, Obrecht M, Sennerby L. Evaluation of a new titanium-zirconium dental implant: a biomechanical and histological comparative study in the mini pig. Clin Implant Dent Relat Res. 2012 Aug;14(4):538-45. doi: 10.1111/j.1708-8208.2010.00289.x. Epub 2010 Jun 25.
- Background: PubMed 23432001Wen B, Zhu F, Li Z, Zhang P, Lin X, Dard M. The osseointegration behavior of titanium-zirconium implants in ovariectomized rabbits. Clin Oral Implants Res. 2014 Jul;25(7):819-25. doi: 10.1111/clr.12141. Epub 2013 Feb 21.
- Allander SV et al. Recommendations for the use of profylactic antibiotics in dentistryLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Endosseous Dental Implant Failure
RecruitingObservational study
Full-Contour Monolithic Zirconia Full-Mouth Implant Supported Rehabilitation Behavior
Endosseous Dental Implant Failure, Accident Caused by Broken Ceramic
RecruitingObservational study
Monolithic Zirconia Full-Mouth Implant Supported Rehabilitation Behavior
Endosseous Dental Implant Failure, Accident Caused by Broken Ceramic
Recruiting
Effect of Immediate Placement and Loading of Compressive Versus Conventional Implants
Other Endosseous Dental Implant Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kostas Bougas, PhD principal investigator
Borås Regional Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Titanium-zirconium and Titanium in people with Endosseous Dental Implant Failure, run by Vastra Gotaland Region at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 13 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Kristina Hultin, Dentist (010-4419590, kristina.e.hultin@vgregion.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in bone loss measured on X-ray (mm) (time frame: Baseline and 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02681250, which also lists 18 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2019.